Moderna Jumps Above 20-Day Moving Average on FDA Flu Vaccine Review. Should You Buy MRNA Stock Here?
Moderna (MRNA) stock closed higher on Wednesday after the FDA reversed its earlier refusal-to-file decision on the company’s mRNA-1010 seasonal…
Moderna (MRNA) stock closed higher on Wednesday after the FDA reversed its earlier refusal-to-file decision on the company’s mRNA-1010 seasonal…
Behind the household COVID-19 name, Moderna, is facing a $5 billion patent-infringement lawsuit over vaccine technology. On February 2, 2026,…
Market Digest: DHR, JPM, PEG, DAL, MRNA finance.yahoo.com #Market #Digest #DHR #JPM #PEG #DAL #MRNA
The mass-produced COVID-19 vaccines built using the mRNA model – which were rapidly manufactured during the global pandemic – could…
The same Nobel-winning mRNA technology that helped curb the Covid-19 pandemic may be poised to transform cancer care. www.bloomberg.com #Cancer…
In the second episode of this four-part series, Rubenstein delved into the breakthroughs in cancer detection and treatment, how artificial…
CureVac NV has settled a long-running patent dispute over mRNA vaccines with Pfizer Inc. and BioNTech SE in the US,…
Trump’s administration halts mRNA vaccine development, sparking WHO fears for emerging pandemic preparedness. The decision by US President Donald Trump’s…
Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the biotechnology company’s…
The Department of Health and Human Services has announced that it will be ending its mRNA vaccine development program, and…